Live Breaking News & Updates on Inovio Pharmaceuticals Stock Down

Stay updated with breaking news from Inovio pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Inovio Pharmaceuticals Inc , Inovio Pharmaceuticals , News Ratings For Inovio Pharmaceuticals Daily , Inovio Pharmaceuticals Stock Down , Vanguard Group Inc , Millennium Management , Institutional Trading Of Inovio Pharmaceuticals , Renaissance Technologies , Capital Partners , Free Report , Pharmaceuticals Stock Down , Street Corp , Vanguard Group , Get Free Report , Inovio Pharmaceuticals Daily ,

Inovio Pharmaceuticals (NASDAQ:INO) Releases Earnings Results, Misses Expectations By $0.02 EPS

Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) announced its earnings results on Wednesday. The biopharmaceutical company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02), RTT News reports. The company had revenue of $0.11 million for the quarter, compared to analyst estimates of $0.20 million. Inovio Pharmaceuticals had […] ....

United States , Ci Private Wealth , Royal Bank , Tower Research Capital , Inovio Pharmaceuticals , Inovio Pharmaceuticals Company Profile , American Century Companies Inc , Earnings History For Inovio Pharmaceuticals , Wealth Group , Inovio Pharmaceuticals Inc , News Ratings For Inovio Pharmaceuticals Daily , Inovio Pharmaceuticals Stock Down , Get Rating , Pharmaceuticals Stock Down , Century Companies , Research Capital , Inovio Pharmaceuticals Daily , Nasdaq Ino ,

Inovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to Underperform at Bank of America

Bank of America cut shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has $2.00 price objective on the biopharmaceutical company’s stock. INO has been the topic of several other research reports. Royal […] ....

United States , Davidb Weiner , Northern Trust Corp , Rafferty Asset Management , Analyst Recommendations For Inovio Pharmaceuticals , Inovio Pharmaceuticals Inc , Institutional Trading Of Inovio Pharmaceuticals , Vanguard Group Inc , Inovio Pharmaceuticals Stock Down , News Ratings For Inovio Pharmaceuticals Daily , Cantor Fitzgerald , Inovio Pharmaceuticals , Royal Bank , Get Rating , Marketbeat Ratings , Pharmaceuticals Stock Down , Director David , Street Corp , Asset Management , Trust Corp , Inovio Pharmaceuticals Daily , Nasdaq Ino , Bank Of America Co ,